Sarah Boyce Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 6 days, 20 hours ago
Sarah Boyce has an estimated net worth of at least $35.7 million*, as of May 7, 2025. They own 305,871 shares of RNA stock. They have sold 879,838 shares of RNA stock since 2021, for an estimated $27.7 million.
Sarah Boyce $RNA SEC Form 4 Insider Trading
Sarah Boyce has filed a total of 24 insider trades in $RNA since 2021. Their most recent trade was a sale of 31,540 shares, made on Mar 20, 2025. Their largest trade was a sale of 164,233 shares, made on Jun 13, 2024. We estimate that they now own 305,871 shares of $RNA, worth an estimated $8.0 million.
Insider Trading at $RNA
There have been a total of 107 insider trades reported at $RNA since 2021, with 800,000 shares purchased and 2.2 million shares sold. The most active insider traders in $RNA stock have been Sarah Boyce, Arthur A Levin, and Michael F Maclean. The most recent trade was a sale of 5,875 shares reported by Kathleen P. Gallagher (Chief Program Officer), made on May 01, 2025.
History of Insider Stock Trades by Sarah Boyce
| Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
|---|---|---|---|---|
RNA
|
Sale | 31,540 | Mar 20, 2025 | March 21, 2025, 6:42 p.m. |
|
RNA
|
Sale | 4,738 | Jan 21, 2025 | Jan. 23, 2025, 9:10 p.m. |
|
RNA
|
Sale | 5,659 | Jan 21, 2025 | Jan. 23, 2025, 9:10 p.m. |
|
RNA
|
Sale | 31,855 | Dec 18, 2024 | Dec. 19, 2024, 7:15 p.m. |
|
RNA
|
Sale | 32,880 | Sep 23, 2024 | Sept. 23, 2024, 9:01 p.m. |
|
RNA
|
Sale | 28,000 | Aug 06, 2024 | Aug. 7, 2024, 5:46 p.m. |
|
RNA
|
Sale | 28,000 | Jul 09, 2024 | July 11, 2024, 4:07 p.m. |
|
RNA
|
Sale | 32,074 | Jun 18, 2024 | June 20, 2024, 6:47 p.m. |
|
RNA
|
Sale | 164,233 | Jun 13, 2024 | June 14, 2024, 6:58 p.m. |
|
RNA
|
Sale | 35,767 | Jun 14, 2024 | June 14, 2024, 6:58 p.m. |
|
RNA
|
Sale | 100,000 | Jun 12, 2024 | June 14, 2024, 6:58 p.m. |
|
RNA
|
Sale | 28,000 | Jun 04, 2024 | June 5, 2024, 5:46 p.m. |
|
RNA
|
Sale | 28,000 | May 07, 2024 | May 7, 2024, 9:52 p.m. |
|
RNA
|
Sale | 28,000 | Apr 02, 2024 | April 3, 2024, 6:16 p.m. |
|
RNA
|
Sale | 28,000 | Mar 12, 2024 | March 12, 2024, 5:29 p.m. |
|
RNA
|
Sale | 84,000 | Mar 08, 2024 | March 12, 2024, 5:29 p.m. |
|
RNA
|
Sale | 84,000 | Mar 01, 2024 | March 5, 2024, 5:53 p.m. |
|
RNA
|
Sale | 5,092 | Jan 22, 2024 | Jan. 23, 2024, 4:13 p.m. |
|
RNA
|
Sale | 900 | Feb 01, 2023 | Feb. 3, 2023, 6:26 p.m. |
|
RNA
|
Sale | 3,221 | Feb 03, 2023 | Feb. 3, 2023, 6:26 p.m. |
|
RNA
|
Sale | 45,879 | Feb 02, 2023 | Feb. 3, 2023, 6:26 p.m. |
|
RNA
|
Sale | 35,045 | Aug 24, 2022 | Aug. 26, 2022, 7:29 p.m. |
|
RNA
|
Sale | 14,855 | Aug 25, 2022 | Aug. 26, 2022, 7:29 p.m. |
|
RNA
|
Sale | 100 | Aug 15, 2022 | Aug. 17, 2022, 9:40 p.m. |
$RNA Executives and Stock Owners with Insider Trades
-
Sarah Boyce, President and CEO
-
Arthur A Levin, Chief Scientific Officer
-
Michael F Maclean, Chief Financial Officer
-
Teresa Mccarthy, Chief Human Resources Officer
-
W. Michael Flanagan, CSTO
-
Kathleen P. Gallagher, Chief Program Officer
-
W. Michael Flanagan, Chief Scientific Officer
-
Steven George Hughes, Chief Medical Officer
-
Roderick Wong, MP and CIO
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.